(Q72926139)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6279406%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Phase II study of oral VP-16-213 in hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6279406%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

main subject

hepatocellular carcinoma

1 reference

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

15 September 2023

1

F Cavalli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6279406%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

author name string

M. Rozencweig

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6279406

15 September 2023

J. Renard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6279406

15 September 2023

A. Goldhirsch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6279406

15 September 2023

H. H. Hansen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6279406

15 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6279406

15 September 2023

publication date

1 October 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6279406%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

30 October 2019

https://api.elsevier.com/content/article/PII:0014296481902917?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

https://api.elsevier.com/content/article/PII:0014296481902917?httpAccept=text/plain

15 September 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

European Journal of Cancer & Clinical Oncology

15 September 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6279406%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6279406%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6279406%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

1079-1082

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6279406%20AND%20SRC:MED&resulttype=core&format=json

Survival after liver resection for cancer

30 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma

15 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study

15 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial

15 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States

15 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

Treatment of hepatocellular carcinoma with adriamycin.Preliminary communication

15 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

Induction of remission in hepatocellular carcinoma with doxorubicin

15 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

A phase II study of neocarzinostatin (NSC 157365) in malignant hepatoma. An Eastern Cooperative Oncology Group pilot study

15 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors.

15 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

VM 26 and VP 16-213: a comparative analysis

15 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

Effects of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleoside transport in HeLa cells

15 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

15 September 2023

Etoposide (VP-16-213)

14

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma

15 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma

15 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0014-2964(81)90291-7

15 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6279406%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference